US equities
|
SPCX
$171.09
▲+0.00%
MU
$1,063.96
▲+0.00%
NVDA
$238.90
▲+0.00%
META
$741.90
▲+0.00%
AMD
$631.75
▲+0.00%
AMZN
$251.40
▲+0.00%
INTC
$116.19
▲+0.00%
STX
$887.09
▲+0.00%
SPCX
$171.09
▲+0.00%
MU
$1,063.96
▲+0.00%
NVDA
$238.90
▲+0.00%
META
$741.90
▲+0.00%
AMD
$631.75
▲+0.00%
AMZN
$251.40
▲+0.00%
INTC
$116.19
▲+0.00%
STX
$887.09
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about TSX:CRDL
Recent news which mentions TSX:CRDL
Cardiol Therapeutics releases positive study results of subcutaneously administered cannabidiol
October 11, 2023
Tags
NASDAQ:CRDL
TSX:CRDL
From
News Direct
Cardiol Therapeutics says first patient enrolled in Phase 2 study of CardiolRx for Pericarditis
January 17, 2023
Tags
NASDAQ:CRDL
TSX:CRDL
From
News Direct
Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis
December 16, 2022
Tags
NASDAQ:CRDL
TSX:CRDL
From
News Direct